Mark A. Clemence
Impact in
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 2
-
- Nosocomial Infections in ICU 2
- Co-authors
- Barry M. Farr (4 shared papers)John A. Jernigan (2 shared papers)Richard L. Guerrant (1 shared paper)
- Journals
- Infection Control and Hospital Epidemiology (2 papers)Microbiology Spectrum (1 paper)American Journal of Infection Control (1 paper)
- Partner nations
- United States
In The Last Decade
Mark A. Clemence
5 papers receiving 333 citations
Peers
Comparison fields: 5 of 57
- Clinical Biochemistry 136
- Applied Microbiology and Biotechnology 39
- Infectious Diseases 235
- Critical Care and Intensive Care Medicine 59
- Emergency Medical Services 62
Countries citing papers authored by Mark A. Clemence
This map shows the geographic impact of Mark A. Clemence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Clemence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Clemence more than expected).
Fields of papers citing papers by Mark A. Clemence
This network shows the impact of papers produced by Mark A. Clemence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Clemence. The network helps show where Mark A. Clemence may publish in the future.
Co-authors
The 3 scholars most cited alongside Mark A. Clemence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 155 | |
| 2 | 1995 | 106 | |
| 3 | 1995 | 56 | |
| 4 | 2015 | 24 | |
| 5 | 1995 | 1 |
About Mark A. Clemence
Mark A. Clemence is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Clinical Biochemistry, Public Health, Environmental and Occupational Health and Emergency Medical Services, having authored 5 papers that have together received 342 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (2 papers), Nosocomial Infections in ICU (2 papers), Central Venous Catheters and Hemodialysis (2 papers), Streptococcal Infections and Treatments (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Vibrio bacteria research studies (1 paper), Marine Toxins and Detection Methods (1 paper) and Identification and Quantification in Food (1 paper). The work is most often cited by research in Clinical Biochemistry (136 citations), Applied Microbiology and Biotechnology (39 citations), Infectious Diseases (235 citations), Critical Care and Intensive Care Medicine (59 citations) and Emergency Medical Services (62 citations). Mark A. Clemence has collaborated with scholars based in United States. Frequent co-authors include Barry M. Farr, John A. Jernigan and Richard L. Guerrant. Their work appears in journals such as Infection Control and Hospital Epidemiology, Microbiology Spectrum and American Journal of Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.